The Oncosearch | Oncotarget

LIGHT/BTLA polymorphisms and antibody-mediated-rejection after heart transplantation Letters to the Editor

Grecia M. MarrÃ³n-LiÃ±ares, LucÃa NÃºÃ±ez, Manuel Hermida-Prieto

Published Nov 1, 2018 · Vol. 9, No. 88 · pp. 35799-35800

Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging Research Paper

Claudia Duranti, Laura Carraresi, Angelica Sette, Matteo Stefanini, Tiziano Lottini, Silvia Crescioli, Olivia Crociani, Luisa Iamele, Hugo De Jonge, Ermanno Gherardi, Annarosa Arcangeli

Published Oct 9, 2018 · Vol. 9, No. 79 · pp. 34972-34989

H19 long non-coding RNA contributes to sphere formation and invasion through regulation of CD24 and integrin expression in pancreatic cancer cells Research Paper

Norihiko Sasaki, Masashi Toyoda, Hisashi Yoshimura, Yoko Matsuda, Tomio Arai, Kaiyo Takubo, Junko Aida, Toshiyuki Ishiwata

Published Oct 5, 2018 · Vol. 9, No. 78 · pp. 34719-34734

Clinical impact of serum soluble SLAMF7 in multiple myeloma Research Paper

Mariko Ishibashi, Saori Soeda, Makoto Sasaki, Hiroshi Handa, Yoichi Imai, Norina Tanaka, Sakae Tanosaki, Shigeki Ito, Takeshi Odajima, Hiroki Sugimori, Toshio Asayama, Mika Sunakawa, Yuta Kaito, Ryosuke Kinoshita, Yasuko Kuribayashi, Asaka Onodera, Keiichi Moriya, Junji Tanaka, Yutaka Tsukune, Norio Komatsu, Koiti Inokuchi, Hideto Tamura

Published Oct 5, 2018 · Vol. 9, No. 78 · pp. 34784-34793

Characterization of murine CEACAM1 in vivo reveals low expression on CD8⁺ T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1 Research Paper

Robbie L. McLeod, Minilik H. Angagaw, Toya Nath Baral, Liming Liu, Raymond Joseph Moniz, Jason Laskey, SuChun Hsieh, Mike Lee, Jin-Hwan Han, Hassan Issafras, Sarah Javaid, Andrey Loboda, Svetlana Sadekova, Joann A. O'Connor, Archie Tse, Juha Punnonen

Published Oct 2, 2018 · Vol. 9, No. 77 · pp. 34459-34470

Functional characterization of phospholipase C-Î³₂ mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder Research Paper

Claudia Walliser, Martin Wist, Elisabeth Hermkes, Yuan Zhou, Anja Schade, Jennifer Haas, Julia Deinzer, Laurent DÃ©sirÃ©, Shawn S.C. Li, Stephan Stilgenbauer, Joshua D. Milner, Peter Gierschik

Published Sep 28, 2018 · Vol. 9, No. 76 · pp. 34357-34378

Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models Research Paper

Maria Quanz, Urs B. Hagemann, Sabine Zitzmann-Kolbe, Beatrix Stelte-Ludwig, Sven Golfier, Cem Elbi, Dominik Mumberg, Karl Ziegelbauer, Christoph A. Schatz

Published Sep 25, 2018 · Vol. 9, No. 75 · pp. 34103-34121

The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model Research Paper

Tatsuzo Mizukami, Hirofumi Kamachi, Yuki Fujii, Fumihiko Matsuzawa, Takahiro Einama, Futoshi Kawamata, Nozomi Kobayashi, Yutaka Hatanaka, Akinobu Taketomi

Published Sep 18, 2018 · Vol. 9, No. 73 · pp. 33844-33852

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models Priority Research Paper

Oi Kwan Wong, Thomas-Toan Tran, Wei-Hsien Ho, Meritxell Galindo Casas, Melinda Au, Marjorie Bateman, Kevin C. Lindquist, Arvind Rajpal, David L. Shelton, Pavel Strop, Shu-Hui Liu

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33446-33458

A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (Macaca fascicularis) Research Paper

Takao Ukaji, Ai Takemoto, Ryohei Katayama, Kengo Takeuchi, Naoya Fujita

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33322-33336

Correction: Antibody targeting TSPAN12/Î²-catenin signaling in vasoproliferative retinopathy Correction

Felicitas Bucher, Martin Friedlander, Kyungmoo Yea

Published Sep 3, 2018 · Vol. 9, No. 69 · pp. 33244-33244

Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer Research Paper

Takahito Sugase, Tsuyoshi Takahashi, Satoshi Serada, Minoru Fujimoto, Tomoharu Ohkawara, Kosuke Hiramatsu, Masahiro Koh, Yurina Saito, Koji Tanaka, Yasuhiro Miyazaki, Tomoki Makino, Yukinori Kurokawa, Makoto Yamasaki, Kiyokazu Nakajima, Kazuhiro Hanazaki, Masaki Mori, Yuichiro Doki, Tetsuji Naka

Published Aug 31, 2018 · Vol. 9, No. 68 · pp. 32917-32928

Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: expression and prognostic significance Research Paper

Barbara Vizio, Monica Boita, Carmen Cristiano, Jasenka Mazibrada, Ornella Bosco, Anna Novarino, Adriana Prati, Savino Sciascia, Giovanni Rolla, Libero Ciuffreda, Giuseppe Montrucchio, Graziella Bellone

Published Aug 28, 2018 · Vol. 9, No. 67 · pp. 32795-32809

Quantitative screening of serum protein biomarkers by reverse phase protein arrays Research Paper

Zhizhou Kuang, Ruochun Huang, Zhimin Yang, Zhiqiang Lv, Xinyan Chen, Fuping Xu, Yu-Hua Yi, Jian Wu, Ruo-Pan Huang

Published Aug 24, 2018 · Vol. 9, No. 66 · pp. 32624-32641

Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer Review

Andrej Jedinak, Kevin R. Loughlin, Marsha A. Moses

Published Aug 21, 2018 · Vol. 9, No. 65 · pp. 32534-32550

Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results Review

Alberto OcaÃ±a, Eitan Amir, Atanasio Pandiella

Published Aug 7, 2018 · Vol. 9, No. 61 · pp. 31915-31919

Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy Research Paper

Anne Bordron, Cristina Bagacean, Audrey Mohr, Adrian Tempescul, Boutahar Bendaoud, StÃ©phanie Deshayes, Florence Dalbies, Caroline Buors, Hussam Saad, Christian Berthou, Jacques-Olivier Pers, Yves Renaudineau

Published Aug 3, 2018 · Vol. 9, No. 60 · pp. 31590-31605

Suppression of SOCS3 enhances TRAIL-induced cell growth inhibition through the upregulation of DR4 expression in renal cell carcinoma cells Research Paper

Michihiro Yabe, Kei Ishibashi, Akifumi Onagi, Ryo Tanji, Ruriko Honda-Takinami, Tomoyuki Koguchi, Kanako Matsuoka, Seiji Hoshi, Junya Hata, Masao Kataoka, Soichiro Ogawa, Hiroyuki Hiraki, Nobuhiro Haga, Yoshiyuki Kojima

Published Aug 3, 2018 · Vol. 9, No. 60 · pp. 31697-31708

Development and evaluation of a novel antibody-photon absorber conjugate reveals the possibility of photoimmunotherapy-induced vascular occlusion during treatment in vivo Research Paper

Yuya Isoda, Wen Piao, Eri Taguchi, Junko Iwano, Shigeki Takaoka, Aiko Uchida, Kiyomi Yoshikawa, Junichi Enokizono, Emi Arakawa, Kazuma Tomizuka, Yasuhisa Shiraishi, Kazuhiro Masuda

Published Jul 31, 2018 · Vol. 9, No. 59 · pp. 31422-31431

Topoisomerase I inhibitor, irinotecan, depletes regulatory T cells and up-regulates MHC class I and PD-L1 expression, resulting in a supra-additive antitumor effect when combined with anti-PD-L1 antibodies Research Paper

Toshiki Iwai, Masamichi Sugimoto, Daiko Wakita, Keigo Yorozu, Mitsue Kurasawa, Kaname Yamamoto

Published Jul 31, 2018 · Vol. 9, No. 59 · pp. 31411-31421

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

LIGHT/BTLA polymorphisms and antibody-mediated-rejection after heart transplantation Letters to the Editor

Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging Research Paper

H19 long non-coding RNA contributes to sphere formation and invasion through regulation of CD24 and integrin expression in pancreatic cancer cells Research Paper

Clinical impact of serum soluble SLAMF7 in multiple myeloma Research Paper

Characterization of murine CEACAM1 in vivo reveals low expression on CD8⁺ T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1 Research Paper

Functional characterization of phospholipase C-Î³₂ mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder Research Paper

Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models Research Paper

The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model Research Paper

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models Priority Research Paper

A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (Macaca fascicularis) Research Paper

Correction: Antibody targeting TSPAN12/Î²-catenin signaling in vasoproliferative retinopathy Correction

Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer Research Paper

Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: expression and prognostic significance Research Paper

Quantitative screening of serum protein biomarkers by reverse phase protein arrays Research Paper

Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer Review

Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results Review

Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy Research Paper

Suppression of SOCS3 enhances TRAIL-induced cell growth inhibition through the upregulation of DR4 expression in renal cell carcinoma cells Research Paper

Development and evaluation of a novel antibody-photon absorber conjugate reveals the possibility of photoimmunotherapy-induced vascular occlusion during treatment in vivo Research Paper

Topoisomerase I inhibitor, irinotecan, depletes regulatory T cells and up-regulates MHC class I and PD-L1 expression, resulting in a supra-additive antitumor effect when combined with anti-PD-L1 antibodies Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

LIGHT/BTLA polymorphisms and antibody-mediated-rejection after heart transplantation Letters to the Editor

Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging Research Paper

H19 long non-coding RNA contributes to sphere formation and invasion through regulation of CD24 and integrin expression in pancreatic cancer cells Research Paper

Clinical impact of serum soluble SLAMF7 in multiple myeloma Research Paper

Characterization of murine CEACAM1 in vivo reveals low expression on CD8+ T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1 Research Paper

Functional characterization of phospholipase C-Î³2 mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder Research Paper

Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models Research Paper

The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model Research Paper

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models Priority Research Paper

A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (Macaca fascicularis) Research Paper

Correction: Antibody targeting TSPAN12/Î²-catenin signaling in vasoproliferative retinopathy Correction

Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer Research Paper

Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: expression and prognostic significance Research Paper

Quantitative screening of serum protein biomarkers by reverse phase protein arrays Research Paper

Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer Review

Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results Review

Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy Research Paper

Suppression of SOCS3 enhances TRAIL-induced cell growth inhibition through the upregulation of DR4 expression in renal cell carcinoma cells Research Paper

Development and evaluation of a novel antibody-photon absorber conjugate reveals the possibility of photoimmunotherapy-induced vascular occlusion during treatment in vivo Research Paper

Topoisomerase I inhibitor, irinotecan, depletes regulatory T cells and up-regulates MHC class I and PD-L1 expression, resulting in a supra-additive antitumor effect when combined with anti-PD-L1 antibodies Research Paper

Characterization of murine CEACAM1 in vivo reveals low expression on CD8⁺ T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1 Research Paper

Functional characterization of phospholipase C-Î³₂ mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder Research Paper